By combining BPC-157 (Body Protection Compound) and TB-500 (Thymosin Beta-4), this protocol targets two distinct but complementary pathways of healing: angiogenesis (blood vessel formation) and cellular migration
The anti-pharma industry position is understandable, with many scandals that have plagued the industry (such as Vioxx, Oxycontin, and several others) without any accountability of the companies or their senior management
Durham Peptides supplies it as the Glow Blend (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg) 70mg at C$160.00 a single co-formulated vial covering all three compounds
Additionally, our lyophilized (freeze-dried) research peptides are highly stable and can withstand elevated temperatures for extended periods of time without compromising quality or efficacy
PubMed Philp, D., Badamchian, M., Scheremeta, B., Nguyen, M., Goldstein, A.L., Kleinman, H.K
Endotoxin levels should remain low to prevent inflammatory responses upon injection